These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29397265)
1. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors. Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265 [TBL] [Abstract][Full Text] [Related]
2. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies. Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404 [TBL] [Abstract][Full Text] [Related]
4. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme. Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145 [TBL] [Abstract][Full Text] [Related]
5. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Farace F; Gross-Goupil M; Tournay E; Taylor M; Vimond N; Jacques N; Billiot F; Mauguen A; Hill C; Escudier B Br J Cancer; 2011 Mar; 104(7):1144-50. PubMed ID: 21386843 [TBL] [Abstract][Full Text] [Related]
6. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients. Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812 [TBL] [Abstract][Full Text] [Related]
7. Alterations of circulating bone marrow-derived VEGFR-2+ progenitor cells in isolated limb perfusion with or without rhTNF-α. Nowak K; Jachol N; Rafat N; Joas E; Beck GCh; Hohenberger P Ann Surg Oncol; 2013 Oct; 20(11):3694-701. PubMed ID: 22948772 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature. Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893 [TBL] [Abstract][Full Text] [Related]
9. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585 [TBL] [Abstract][Full Text] [Related]
10. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Igreja C; Courinha M; Cachaço AS; Pereira T; Cabeçadas J; da Silva MG; Dias S Haematologica; 2007 Apr; 92(4):469-77. PubMed ID: 17488657 [TBL] [Abstract][Full Text] [Related]
11. Increased serum levels of fractalkine and mobilisation of CD34 Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472 [TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications. Kulwas A; Drela E; Jundziłł W; Góralczyk B; Ruszkowska-Ciastek B; Rość D J Diabetes Complications; 2015 Jul; 29(5):686-90. PubMed ID: 25872462 [TBL] [Abstract][Full Text] [Related]
13. Correlation between circulating endothelial progenitor cells and serum carcinoembryonic antigen level in colorectal cancer. Li Y; Liu J; Zhao Z; Wen L; Li H; Ren J; Liu H Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):307-312. PubMed ID: 29377980 [TBL] [Abstract][Full Text] [Related]
14. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction. Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496 [TBL] [Abstract][Full Text] [Related]
15. Serum vascular endothelial growth factors a, C and d in human breast tumors. Gisterek I; Matkowski R; Lacko A; Sedlaczek P; Szewczyk K; Biecek P; Halon A; Staszek U; Szelachowska J; Pudelko M; Bebenek M; Harlozinska-Szmyrka A; Kornafel J Pathol Oncol Res; 2010 Sep; 16(3):337-44. PubMed ID: 19821158 [TBL] [Abstract][Full Text] [Related]
16. Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Yoon SS; Segal NH; Olshen AB; Brennan MF; Singer S Ann Oncol; 2004 Aug; 15(8):1261-6. PubMed ID: 15277268 [TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853 [TBL] [Abstract][Full Text] [Related]
18. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Feldman AL; Pak H; Yang JC; Alexander HR; Libutti SK Cancer; 2001 Apr; 91(8):1525-9. PubMed ID: 11301401 [TBL] [Abstract][Full Text] [Related]
19. Identification and significance of mobilized endothelial progenitor cells in tumor neovascularization of renal cell carcinoma. Yu P; Ge YZ; Zhao Y; Wu JP; Wu R; Zhou LH; Jia RP Tumour Biol; 2014 Sep; 35(9):9331-41. PubMed ID: 24943683 [TBL] [Abstract][Full Text] [Related]
20. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]